Alumis

ALMS · NASDAQ

$6.70+$0.36 (+5.68%)TodayMarket closed · Oct 20, 7:42 PM ET

Prev close $6.34

Latest news

Press releaseOct 9, 4:00 AM ETGlobe Newswire
Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures
NewsSep 2, 10:26 AM ETAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
NewsSep 1, 1:07 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsSep 1, 12:05 PM ETAvi Kapoor
Crude Oil Surges 3%; ISM Manufacturing PMI Falls In August
NewsSep 1, 10:56 AM ETVandana Singh
Why Is Alumis Stock Falling Tuesday?
NewsSep 1, 9:39 AM ETAvi Kapoor
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
NewsSep 1, 7:33 AM ET
Alumis Announces Its Phase 2b LUMUS Study Of Envudeucitinib To Treat Lupus Erythematosus Failed To Meet Primary, Secondary Endpoints
Press releaseSep 1, 7:30 AM ETGlobe Newswire
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
Press releaseAug 13, 4:01 PM ETGlobe Newswire
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
NewsAug 11, 9:57 AM ETVandana Singh
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates
Press releaseAug 10, 4:05 PM ETGlobe Newswire
Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies
Press releaseMay 14, 4:05 PM ETGlobe Newswire
Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
NewsMar 30, 12:54 PM ETVandana Singh
Why Is Alumis Stock Falling Monday?
Press releaseMar 28, 1:30 PM ETGlobe Newswire
Alumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis
Press releaseMar 19, 4:05 PM ETGlobe Newswire
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
NewsJan 15, 4:12 PM ETPiero Cingari
David Vs. Goliath: Why Small Cap Stocks Are Crushing The Magnificent 7
NewsJan 6, 8:45 PM ETShivdeep Dhaliwal
Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today
NewsJan 6, 12:58 PM ETAvi Kapoor
Dow Jumps Over 400 Points; US Services Activity Falls In December
NewsJan 6, 10:47 AM ETVandana Singh
Alumis Skin Drug Shows Clear Benefits In Late Trials, Stock Soars
NewsJan 6, 10:07 AM ETAvi Kapoor
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
NewsJan 6, 9:49 AM ETAvi Kapoor
US Stocks Mixed; Nasdaq Gains Over 50 Points
Press releaseJan 6, 9:30 AM ETGlobe Newswire
Morning Market Brief: Breakthrough Biology Meets Scalable Platforms as Innovators Surge into Focus
NewsJan 6, 4:45 AM ETAvi Kapoor
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
NewsDec 5, 10:53 AM ETAvi Kapoor
ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday
NewsOct 20, 8:10 AM ETAvi Kapoor
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Press releaseApr 16, 5:31 PM ETBusiness Wire
ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN
Press releaseApr 1, 10:51 AM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, BECN, SLRN, ALMS on Behalf of Shareholders
NewsApr 1, 10:32 AM ETAvi Kapoor
Progress Software Posts Upbeat Results, Joins Microvast, PVH And Other Big Stocks Moving Higher On Tuesday
NewsApr 1, 7:56 AM ETAvi Kapoor
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Press releaseFeb 10, 6:15 PM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, FNA, ALMS, HEES on Behalf of Shareholders
Press releaseFeb 10, 12:16 PM ETBusiness Wire
ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN
Press releaseFeb 7, 3:22 PM ETPRNewswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ACELYRIN, INC.
NewsFeb 7, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseFeb 6, 9:50 PM ETBusiness Wire
ALMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Alumis Inc. is Fair to Shareholders
NewsDec 13, 8:53 AM ETAvi Kapoor
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
NewsOct 31, 11:37 AM ETAvi Kapoor
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Press releaseAug 13, 4:05 PM ETGlobe Newswire
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
NewsJul 24, 3:18 PM ETVandana Singh
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

12 Health Care Stocks Moving In Tuesday's Intraday Session

Crude Oil Surges 3%; ISM Manufacturing PMI Falls In August

Why Is Alumis Stock Falling Tuesday?

Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings

Alumis Announces Its Phase 2b LUMUS Study Of Envudeucitinib To Treat Lupus Erythematosus Failed To Meet Primary, Secondary Endpoints

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates

Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies

Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements

Why Is Alumis Stock Falling Monday?

Alumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements

David Vs. Goliath: Why Small Cap Stocks Are Crushing The Magnificent 7

Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today

Dow Jumps Over 400 Points; US Services Activity Falls In December

Alumis Skin Drug Shows Clear Benefits In Late Trials, Stock Soars

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

US Stocks Mixed; Nasdaq Gains Over 50 Points

Morning Market Brief: Breakthrough Biology Meets Scalable Platforms as Innovators Surge into Focus

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket

ServiceTitan Posts Upbeat Q3 Results, Joins DigitalBridge, Rubrik, Victoria's Secret And Other Big Stocks Moving Higher On Friday

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, BECN, SLRN, ALMS on Behalf of Shareholders

Progress Software Posts Upbeat Results, Joins Microvast, PVH And Other Big Stocks Moving Higher On Tuesday

Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, FNA, ALMS, HEES on Behalf of Shareholders

ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ACELYRIN, INC.

12 Health Care Stocks Moving In Friday's Pre-Market Session

ALMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Alumis Inc. is Fair to Shareholders

Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements

Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation